List of British Stocks on U.S. Exchanges
The companies on this list are headquartered in the United Kingdom and listed on major U.S. exchanges. The most common means of listing is through American Depository Receipts (ADRs). A list of ETFs focusing on companies from United Kingdom can be accessed through the link below:
ETFs Focusing on the United Kingdom
Other foreign companies listed on U.S. exchanges can be found through our foreign stock section:
Foreign Stocks on U.S. Exchanges
Select the company’s link to access charts, news links and company website and social media information.
Asset Management
BrightSphere Investment Group plc (BSIG)
Janus Henderson Group plc (JHG)
Automobiles
Fiat Chrysler Automobiles N.V. (FCAU) (Alfa Romeo, Chrysler, Dodge, Ferrari, Fiat, Jeep, Maserati, and Ram)
Auto Parts
Delphi Automotive Plc. (DLPH) (Automotive and commercial; diverse product line)
Banks
Lloyds Banking Group plc (LYG)
Royal Bank Scotland plc (The) (RBS)
Biotech and Pharmaceuticals
Adaptimmune Theapeutics plc (ADAP) (Biopharmaceutical company: cancer immunotherapy products)
Akari Therapeutics, Plc (AKTX) (Biopharmaceutical company: therapeutics to treat orphan autoimmune and inflammatory diseases)
AstraZeneca Plc. (AZN) (Biopharmaceutical company: autoimmune, cardiovascular, infection, inflammation, metabolic, neuroscience, oncology, respiratory)
GlaxoSmithKline Plc. (GSK) (Prescription medicines, vaccines and consumer healthcare products)
GW Pharmaceuticals Plc (GWPH) (Cannabinoid prescription medicines: Sativex® (multiple sclerosis); Epidiolex® (childhood epilepsy))
Midatech Pharma plc (MTP) (Oncology treatment and supportive care products)
Motif Bio plc (MTFB) (Biopharmaceutical company, development of antibiotics for infections)
Mylan Inc. (MYL) (Generic, branded generic and specialty pharmaceuticals)
Nightstar Therapeutics plc (NITE) (IPO September 28, 2017; gene therapy company: rare inherited retinal diseases)
NuCana plc (NCNA) (IPO September 28, 2017; biopharmaceutical company: medicines designed to overcome key cancer resistance mechanisms using proprietary ProTide technology)
Summit Therapeutics Plc. (SMMT) (Biopharmaceutical company: Duchenne Muscular Dystrophy, infectious disease caused by the bacteria C. difficile)